Archives: Speakers

Yarhy Flores is a researcher in Human–AI Collaboration focused on applying artificial intelligence to clinical research and operations. With a background in management and computer science, his work explores how AI tools can be designed to meet the needs of clinical researchers, improving efficiency and decision-making across the trial lifecycle.

Katie Norton is a transformational leader with over 20 years of experience building and scaling patient recruitment, feasibility, and engagement functions for global clinical trials. She has led high-impact organizational change at companies including Moderna, EMD Serono, and Takeda, creating innovative, patient-centered strategies that accelerate development and deliver meaningful results.

April Mattison-Wolfe brings 24 years of Clinical Operations experience to TransPerfect’s Trial Interactive (TI) Technical Services, including 7+ years as a Clinical Operations Trainer and Clinical Business Systems Analyst. With expertise from both sponsors and CROs, she helps TI clients identify CTMS needs and configure tailored solutions. April’s deep understanding of clinical systems requirements and pharmaceutical business practices ensures clients optimize their clinical trial management systems for efficiency and compliance.

Katherine Cianciarelli is a senior product manager with almost a decade of experience in eClinical technology. An engineer by trade, she focuses on building practical AI tools that improve clinical research workflows. Her work centers on finding smart ways to optimize processes while ensuring responsible and compliant technology use, always seeking to bridge the gap between technical innovation and real-world research needs.

A seasoned leader with over two decades of experience in clinical development, Sangmi Lee is currently the Head of Clinical Development at ABL Bio Inc., where she spearheads the company’s oncology pipeline. Her extensive career spans both global and local pharmaceutical landscapes, including leadership roles at Novartis, Chong Kun Dang, and GreenCross.

Specializing in early-stage development, Sangmi Lee has deep expertise in advancing complex therapeutic modalities, with a particular focus on T-cell engagers, bispecific antibodies, and bispecific ADCs. Her presentation, “Optimizing T Cell Engaging Therapies from Preclinical Study to Human Clinical Trial,” will draw on her comprehensive background in translating cutting-edge science into successful human clinical trials.

Joanna has spent the past three years immersed in food sustainability, helping global businesses design and deliver ambitious decarbonisation pathways. With a background in large-scale transformation programmes across FTSE100 companies, she brings over eight years of experience driving change at scale.Passionate about turning sustainability goals into action, Joanna believes the key ingredients for success are education and upskilling, making smart use of data, and ensuring every employee feels part of the journey. Her work blends strategic vision with practical delivery, helping organisations not only reduce their footprint but also create momentum and excitement along the way.